INSIGHTS ON DRUG DEVELOPMENT

• What Are ATMPs And Why Do They Matter?

  Delves into the evolution of Advanced Therapy Medicinal Products (ATMPs), exploring their complex development, revolutionary potential in treating diseases, and the intricacies of cell and gene therapies.

• White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And Challenges

  Explore the potential of spray-dried nasal formulations for biologics to achieve excellent stability and targeted delivery, paving the way for innovative and effective therapeutic solutions.

• VEGF Signaling Pathway

  In Alzheimer's disease, reduced VEGF levels are linked to neurodegeneration, which can offer therapeutic potential. Discover how experimental treatments show promise in reducing memory impairment and beta-amyloid deposition.

• Can Collaboration Close Biopharma's Talent Gap For Good?

  Biopharma innovation is accelerating, but workforce shortages threaten progress. See how strengthening collaboration is essential to developing the skills needed for emerging therapies.

• Color Consistency In UHMWPE Medical Textiles

  3/26/2026

  Color consistency improves surgical visibility, differentiation, and workflow efficiency, requiring medical textiles that deliver strength, compliance, and reliable quality in every color.

• Advancing Drug Development Through Expertise In Energetic Chemistry

  12/5/2025

  Overcoming development complexity requires robust process safety. Solutions can safely scale challenging reactions, like click chemistry and cryogenic organometallics, improving efficiency and results.

• Solutions For Overcoming New Challenges In Pharmaceutical Development

  7/24/2026

  Eric Fang on meeting new pharmaceutical development challenges with a two-part investment — technology that answers R&D questions faster, and scientists given the support to tackle what technology can't.

• Formulation Strategies For Enabling "Undevelopable" Compounds

  4/29/2025

  KinetiSol enhances bioavailability of poorly soluble drugs like Vemurafenib by producing dense amorphous dispersions, outperforming traditional MBP methods in pharmacokinetics and dissolution.

• Lightning-Link^® Conjugation Kits: Consistent Performance On A Broad Scale

  9/26/2024

  Learn about labeling technology offering a transformative solution through direct antibody labeling without the need for post-conjugation purification, thereby mitigating antibody loss and ensuring reproducible results.